Improving cancer immunotherapy through nanotechnology

Immunity, Inflammation, and Cancer

Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089

Understanding the tumor immune microenvironment (TIME) for effective therapy

Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030

Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia

Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448

Nanotechnology-based multifunctional vaccines for cancer immunotherapy

Xie, X., Song, T., Feng, Y., Zhang, H., Yang, G., Wu, C., You, F., Liu, Y., & Yang, H. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135505 · Cited by 27

Nanospiky Copper Peroxide as Lactate-Modulating Nanoadjuvant To Induce Cuproptosis and Pyroptosis for Enhanced Tumor Immunotherapy

Liu, B., Chen, X., Zhen, Z., Li, J., Zheng, P., Feng, L., Gai, S., Yang, P., Cheng, Z., & Lin, J. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c04293 · Cited by 26

Nanotechnologies for enhancing cancer immunotherapy

Yang, J., Wang, C., Shi, S., & Dong, C. (2020) · Nano Research · doi:10.1007/s12274-020-2904-8 · Cited by 26

Supramolecular biomaterials for enhanced cancer immunotherapy

Zhang, H., Zhu, J., Fang, T., Li, M., Chen, G., & Chen, Q. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00048b · Cited by 26

Dual-modulation of immunosuppressive pathways using sono-activatable semiconducting polymer nanofeedbacks for cancer immunotherapy

Yu, N., Li, M., Zhang, Y., Wang, F., Yu, X., Cai, R., & Li, J. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101944 · Cited by 26

Approved delivery strategies for biopharmaceuticals

Zoulikha, M., Chen, Z., Wu, J., & He, W. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110225 · Cited by 26

Chiral Nanofibers of Camptothecin Trigger Pyroptosis for Enhanced Immunotherapy

Gao, F., Qiu, X., Baddi, S., He, S., Wang, S., Zhao, C., Dou, X., & Feng, C. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202423446 · Cited by 25

Synthesis of Hydrogel-Based Microgels and Nanogels Toward Therapeutic and Biomedical Applications

Choi, Y., Koh, H. Y., Han, J. Y., & Seo, S. (2025) · Applied Sciences · doi:10.3390/app15031368 · Cited by 25

Self-assembling nanocomposites for smart drug delivery: towards personalized and stimuli-responsive therapeutics

Emadi, R., Amiri, Z., Moghadam, F. M., Raoufi, S., Moradi, M. Z., Asadi, S., Cho, W. C., Park, J. H., Voosough, A., Farani, M. R., et al. (2026) · RSC Advances · doi:10.1039/d5ra07117h · Cited by 25

Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies

Zafar, A., Hasan, M., Tariq, T., & Dai, Z. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00437 · Cited by 25

Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy

Yan, W., Lang, T., Yuan, W., Yin, Q., & Li, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00976-6 · Cited by 25

Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy

Meng, Y., Huang, J., Ding, J., Zhou, H., Li, Y., & Zhou, W. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101018 · Cited by 25

Regulation of CTLs/Tregs via Highly Stable and Ultrasound‐Responsive Cerasomal Nano‐Modulators for Enhanced Colorectal Cancer Immunotherapy

Zhang, J., Sun, L., Jiang, L., Xie, X., Wang, Y., Wu, R., Tang, Q., Sun, S., Zhu, S., Liang, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202400485 · Cited by 25

Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy

Sun, X., Xu, X., Li, F., Wang, H., Sun, Y., Yang, H., Li, X., Kong, B., Hou, H., Liu, H., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202502646 · Cited by 24

Engineering immunity via skin-directed drug delivery devices

Polaka, S., Makwana, V., Vasdev, N., Sheth, A. P., Rajpoot, K., Sengupta, P., & Tekade, R. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.013 · Cited by 24

Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies

Jia, W., Huang, Z., Zhou, L., Liou, Y., Virgilio, F. D., Ulrich, H., Illés, P., Zhang, W., Huang, C., & Tang, Y. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100988 · Cited by 24

Multifunctional Nanomodulators Regulate Multiple Pathways To Enhance Antitumor Immunity

Zheng, Y., Zhang, Z., Liu, Q., Zhao, Y., Zheng, C., Hao, J., Yi, K., Wang, Y., Wang, C., Zhao, X., et al. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00513 · Cited by 23

Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy

Japir, A. A.-W. M. M., Ke, W., Li, J., Mukerabigwi, J. F., Ibrahim, A., Wang, Y., Li, X., Zhou, Q., Mohammed, F., & Ge, Z. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.015 · Cited by 23

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer

Bom, A. P. D. A., Neves, P., de Almeida, C. E. B., Silva, D., & Missailidis, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120684 · Cited by 23

The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicine

Chen, H., Cheng, H., Wu, W., Li, D., Mao, J., Chu, C., & Liu, G. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.03.024 · Cited by 23

Intracellular Self‐Immolative Polyprodrug with Near‐Infrared Light Guided Accumulation and in Vivo Visualization of Drug Release

Cheng, D., Zhang, X., Chen, S., Xu, X., Wang, H., & Qiao, Z. (2021) · Advanced Materials · doi:10.1002/adma.202109528 · Cited by 23

A T‐Cell Inspired Sonoporation System Enhances Low‐Dose X‐Ray‐Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin‐E Expression

Yin, H., Hu, X., Xie, C., Li, Y., Gao, Y., Zeng, H., Zhu, W., Xie, D., & Wang, Q. (2024) · Advanced Materials · doi:10.1002/adma.202401384 · Cited by 22

A prodrug nanoplatform via esterification of STING agonist and IDO inhibitor for synergistic cancer immunotherapy

Syeda, M. Z., Hong, T., Zhang, M., Han, Y., Zhu, X., Ying, S., & Tang, L. (2022) · Nano Research · doi:10.1007/s12274-022-4598-6 · Cited by 22

Immunoadjuvant-Modified Rhodobacter sphaeroides Potentiate Cancer Photothermal Immunotherapy

Niu, M., Chen, Q., Chen, Z., Liu, X., Huang, Q., Liang, J., Zhong, Z., Cheng, H. L., & Zhang, X. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c03191 · Cited by 22

Nanomedicine: From where are we coming and where are we going?

Couvreur, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.020 · Cited by 22

Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy

Zhang, Z., Yu, L., Liu, W., & Huang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.044 · Cited by 21

Immunotoxin Screening System: A Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities

Hamamichi, S., Fukuhara, T., & Hattori, N. (2020) · Toxins · doi:10.3390/toxins12100658 · Cited by 24

Delineating the Role of Tailored Gold Nanostructures at the Biointerface

Fatrekar, A. P., Morajkar, R. V., Krishnan, S., Dusane, A., Madhyastha, H., & Vernekar, A. A. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00998 · Cited by 21

Nanomedicine-based adjuvant therapy: a promising solution for lung cancer

Xu, Y., Hsu, J. C., Xu, L., Chen, W., Cai, W., & Wang, K. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01958-4 · Cited by 21

Innovative integration of nanomedicines and phototherapy to modulate autophagy for enhanced tumor eradication

Ding, Q., Chen, H., Zhang, Y., Yang, J., Li, M., He, Q., & Mei, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.071 · Cited by 21

Immunologically modified enzyme-responsive micelles regulate the tumor microenvironment for cancer immunotherapy

Han, Z., Gong, C., Li, J., Guo, H., Chen, X., Jin, Y., Gao, S., & Tai, Z. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100170 · Cited by 21

Conjugated STING agonists

Qu, S., & Dai, H. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102530 · Cited by 22

Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines

Berti, C., Graciotti, M., Boarino, A., Yakkala, C., Kandalaft, L. E., & Klok, H. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100356 · Cited by 20

Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy

Wang, S., Liu, X., Yang, M., Ouyang, L., Ding, J., Wang, S., & Zhou, W. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.06.001 · Cited by 20

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer

Liao, Z., Huang, K., Kempson, I. M., Li, H., Tseng, S. ‐., & Yang, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.043 · Cited by 20

An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy

Zhang, Z., Chen, X., Gong, N., Qing, G., Zhang, Y., Shi, Y., Brenner, J. S., Li, F., Xu, F., & Liang, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.087 · Cited by 19

Modified probiotics and the related combinatorial therapeutics

Zhao, L., Niu, M., Ma, Z., He, F., Liu, X., Gong, X., Chai, Z., Wang, Z., Feng, Q., & Wang, L. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.021 · Cited by 20

Multifunctional Superparamagnetic Copper Iron Oxide Nanoparticles for Synergistic Cancer Therapy via Magnetic Hyperthermia, Oxidative Stress and Immune Reprogramming

Cai, Y., Kang, X., Zhou, L., Wu, S., Wang, C., Wu, S., Huang, C.-H., Wang, Q., Chang, Y., Babu, R. J., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202425286 · Cited by 19

Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy

Lin, X., Li, F., Gu, Q., Wang, X., Zheng, Y., Li, J., Guan, J., Yao, C., & Liu, X. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.029 · Cited by 19

A biocompatible nanoparticle-based approach to inhibiting renal ischemia reperfusion injury in mice by blocking thrombospondin-1 activity

Hou, Y., Xin, Y., Liu, S., Li, Y., Meng, X., Wang, J., Xu, Z., Sun, T., & Yang, Y. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17052 · Cited by 19

Across-Cancer Immune Responses Induced by Nanovaccines or Microvaccines to Prevent Different Cancers and Cancer Metastasis

Diao, L., Ma, L., Cheng, J., Pan, Y., Peng, Z., Zhang, L., Xu, M., Li, Y., Zhang, X., Jiang, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105511 · Cited by 19

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck

Xu, Q., Fang, M., Zhu, J., Dong, H., Cao, J., Yan, L., Leonard, F., Oppel, F., Sudhoff, H. H., Kaufmann, A. M., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47068 · Cited by 19

Methylene blue associated with maghemite nanoparticles has antitumor activity in breast and ovarian carcinoma cell lines

Silva, A. L. G., de Carvalho, N. V., Paterno, L. G., de Moura, L. D., Filomeno, C. L., de Paula, E., & Báo, S. N. (2021) · Cancer Nanotechnology · doi:10.1186/s12645-021-00083-x · Cited by 19

Promotion of ICD via Nanotechnology

Qin, Y., Zhang, H., Li, Y., Xie, T., Yan, S., Wang, J., Qu, J., Ouyang, F., Lv, S., Guo, Z., et al. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300093 · Cited by 18

New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment

Jiang, P., Liang, B., Zhang, Z., Fan, B., Zeng, L., Zhou, Z., Mao, Z., Xu, Q., Yao, W., & Shen, Q. (2023) · RSC Advances · doi:10.1039/d3ra03099g · Cited by 18

Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity

Cao, X., Xu, Y., Zhou, C., Huo, J., Su, S., Liu, L., Zhu, Z., Li, L., Jia, W., Wang, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202302910 · Cited by 18

Antigen self-presenting dendrosomes swallowing nanovaccines boost antigens and STING agonists codelivery for cancer immunotherapy

Xia, J., Chen, X., Dong, M., Liu, S., Zhang, L., Pan, J., & Wang, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122998 · Cited by 18

Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies

Ajina, R., Zahavi, D. J., Zhang, Y., & Weiner, L. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.005 · Cited by 18

Vaccine Nanoparticles Derived from Mung Beans for Cancer Immunotherapy

Wang, N., Zhang, G., Sun, H., Tian, Y., Hao, J., & Cui, J. (2021) · Chemistry of Materials · doi:10.1021/acs.chemmater.1c00629 · Cited by 18

Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy

Shim, M. K., Song, S. K., Jeon, S. I., Hwang, K. Y., & Kim, K. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2081683 · Cited by 18

Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy

Parra‐Nieto, J., de Cárcer, I. A., del Cid, M. A. G., Jiménez‐Falcao, S., Gónzalez‐Larre, J., & Baeza, A. (2024) · Advanced Materials Interfaces · doi:10.1002/admi.202400343 · Cited by 17

Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

Wang, Z., Wang, Y., He, Z., & Liu, C. (2025) · Advanced Science · doi:10.1002/advs.202509890 · Cited by 20

Cyclo-γ-polyglutamic acid-coated dual-responsive nanomicelles loaded with doxorubicin for synergistic chemo-photodynamic therapy

Wang, C., Wang, B., Zou, S., Wang, B., Liu, G., Zhang, F., Wang, Q., He, Q., & Zhang, L. (2021) · Biomaterials Science · doi:10.1039/d1bm00713k · Cited by 17

Effect of Ag Nanoparticles on Denitrification and Microbial Community in a Paddy Soil

Zhang, X., Dang, D., Zheng, L., Wu, L., Wu, Y., Li, H., & Yu, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.785439 · Cited by 17

Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy

Katopodi, T., Petanidis, S., Tsavlis, D., Anestakis, D., Charalampidis, C., Chatziprodromidou, I. P., Eskitzis, P., Zarogoulidis, P., Kosmidis, C. S., Matthaios, D., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1042125 · Cited by 17

Novel emerging nano-assisted anti-cancer strategies based on the STING pathway

Li, X., Wang, H., Chen, Y., Li, Z., Liu, S., Guan, W., Lin, Y., Cao, C., Zheng, W., & Wu, J. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0023 · Cited by 17

Advances in cancer diagnosis and therapy by alginate-based multifunctional hydrogels: A review

Wang, Z., Han, X., Sun, G., Yu, M., Qin, J., Zhang, Y., & Ding, D. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137707 · Cited by 17

DNA lesion-gated dumbbell nanodevices enable on-demand activation of the cGAS-STING pathway for enhancing cancer immunotherapy

Zhao, M.-L., Lei, Y., Tang, J., Li, W., Cao, X., Liang, W., Yuan, R., Yang, C. J., & Zhuo, Y. (2024) · Chemical Science · doi:10.1039/d4sc06493c · Cited by 17

CaCO3-Encapsulated Au Nanoparticles Modulate Macrophages toward M1-like Phenotype

Yang, S., Zhang, Y., Lü, S., Yang, L., Yu, S., & Yang, H. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01608 · Cited by 17

Enhanced Antitumor Efficacy through an “AND gate” Reactive Oxygen‐Species‐Dependent pH‐Responsive Nanomedicine Approach

Jäger, E., Humajová, J., Dölen, Y., Kučka, J., Jäger, A., Konefał, R., Pankrác, J., Pavlová, E., Heizer, T., Šefc, L., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100304 · Cited by 18

In vitro evidence of oncofetal antigen and TLR-9 agonist co-delivery by alginate nanovaccines for liver cancer immunotherapy

Pei, M., Li, H., Zhu, Y., Lü, J., & Zhang, C. (2022) · Biomaterials Science · doi:10.1039/d1bm02021h · Cited by 17

Nanomaterials in cancer starvation therapy: pioneering advances, therapeutic potential, and clinical challenges

Tran, N. A., Moonshi, S. S., Lam, A. K.-Y., Lu, C. T., Vu, C. Q., Arai, S., & Ta, H. T. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10267-1 · Cited by 16

Microenvironmental Behaviour of Nanotheranostic Systems for Controlled Oxidative Stress and Cancer Treatment

Rehman, Y., Qutaish, H., Kim, J. H., Huang, X., Alvi, S., & Konstantinov, K. (2022) · Nanomaterials · doi:10.3390/nano12142462 · Cited by 16

Synergy of Polydopamine Nanovaccine and Endostar Alginate Hydrogel for Improving Antitumor Immune Responses Against Colon Tumor

Yang, Y., Wang, N., Tian, X., Wang, X., Yang, J., Leng, X., & Zhang, H. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s372048 · Cited by 16

Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment

Kiss, B., & Borbely, J. D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061761 · Cited by 16

Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune Responses

Stickdorn, J., Czysch, C., Medina‐Montano, C., Stein, L., Xu, L., Scherger, M., Schild, H., Grabbe, S., & Nuhn, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015417 · Cited by 16

Immunoscore Guided Cold Tumors to Acquire “Temperature” Through Integrating Physicochemical and Biological Methods

Liu, J., Xu, M., & Yuan, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0002 · Cited by 16

Identification of Prognostic Immune‐Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study

Wu, G., Deng, Z., Jin, Z., Wang, J., Xu, B., Zeng, J., Peng, M., Zhang, W., & Guo, Y. (2020) · BioMed Research International · doi:10.1155/2020/1346045 · Cited by 16

Fever-Inducible Lipid Nanocomposite for Boosting Cancer Therapy through Synergistic Engineering of a Tumor Microenvironment

Qu, D., Qin, Y., Liu, Y., Liu, T., Liu, C., Han, T., Chen, Y., Ma, C., & Li, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c06949 · Cited by 16

Engineering nanotheranostic strategies for liver cancer

Cao, L., Zhu, Y., Wu, Z., Wang, G., & Cheng, H. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1213 · Cited by 16

Personalized gel-droplet monocyte vaccines for cancer immunotherapy

Tian, Y., Xu, C.-M., Jiao, F., Huangfu, Y., Wang, K., & Zhang, Z. (2021) · Lab on a Chip · doi:10.1039/d1lc00646k · Cited by 16

Build an implanted “arsenal”: detachable microneedles for NIR-triggered cancer photothermo-chemotherapy

Yu, W., Li, X., Huang, Y., Chen, Y., Gao, Q., Wang, Y., & Ji, J. (2021) · Biomaterials Science · doi:10.1039/d1bm00520k · Cited by 16

An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection In Vivo for Promoted Antitumor Immunity

Gao, Z., Miao, Z., Jia, S., Zhang, D., Zhang, H., Tian, J., Zhao, J., Xin, J., & Ding, D. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c09791 · Cited by 15

Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities

Wang, J., Zhao, Y., & Nie, G. (2023) · Medical Review · doi:10.1515/mr-2023-0028 · Cited by 15

Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies

Mishchenko, T. A., Balalaeva, I. V., Turubanova, V. D., Saviuk, M. O., Shilyagina, N. Y., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.05.003 · Cited by 16

Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy

Mujahid, K., Rana, I., Suliman, I. H., Li, Z., Wu, J., He, H., & Nam, J. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00808 · Cited by 16

Dual-enzyme decorated semiconducting polymer nanoagents for second near-infrared photoactivatable ferroptosis-immunotherapy

Liu, Y., Lu, R., Li, M., Cheng, D., Wang, F., Ouyang, X., Zhang, Y., Zhang, Q., Li, J., & Peng, S. (2024) · Materials Horizons · doi:10.1039/d3mh01844j · Cited by 15

Engineered oncolytic bacteria for malignant solid tumor treatment

Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 16

Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions

Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 15

Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy

An, X., Zeng, Y., Liu, C., & Liu, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010022 · Cited by 15

Hitchhiking Delivery Systems: Therapeutic Hydrogels as Advanced Tools for Immunomodulatory Applications

Zhao, Y., Song, S., Zhang, J., Ren, X., & Zhao, Y. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00923 · Cited by 17

Recent advances in the nanoparticle-based targeted cancer treatment: A review

Uddin, H. M. W., Progoti, Q. R. M., Rahman, A. F. M. M., Osman, A. I., & Salem, K. S. (2025) · Next Bioengineering · doi:10.1016/j.nxbio.2025.100011 · Cited by 17

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer

Xu, Q., Chen, Y., Jin, Y., Wang, Z., Dong, H., Kaufmann, A. M., Albers, A. E., & Qian, X. (2022) · Viruses · doi:10.3390/v14122824 · Cited by 14

Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy

Huang, Z., Wei, C., Chen, Y., Jiang, Q., Wang, Y.-Q., Wang, Y., Xu, T., Lü, N., Huang, Z., & Xu, X. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.061 · Cited by 14

Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity

Motlagh, P. E., Novin, A. G., Ghahari, F., Nikzad, A., Khoshandam, M., Mardani, S., Khanbabaei, H., Farsinejad, A., Sathyapalan, T., Sahebkar, A., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_10 · Cited by 14

Assessment of Cellular Uptake Efficiency According to Multiple Inhibitors of Fe3O4-Au Core-Shell Nanoparticles: Possibility to Control Specific Endocytosis in Colorectal Cancer Cells

Park, B. G., Kim, Y. J., Min, J. H., Cheong, T.-C., Nam, S. H., Cho, N., Kim, Y. K., & Lee, K. B. (2020) · Nanoscale Research Letters · doi:10.1186/s11671-020-03395-w · Cited by 14

Is Immunotherapy the Holy Grail for Pancreatic Cancer?

Andersson, R. E., Pereira, C., Bauden, M. P., & Ansari, D. (2019) · Immunotherapy · doi:10.2217/imt-2019-0164 · Cited by 14

Nanomedicines: intervention in inflammatory pathways of cancer

Anwar, F., Naqvi, S., Shams, S., Sheikh, R. A., Al-Abbasi, F. A., Asseri, A. H., Baig, M. R., & Kumar, V. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01217-w · Cited by 13

Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023

Hou, Y., Li, Y., Zhang, Y., Zhang, J., & Wu, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1423212 · Cited by 13

Engineering disease analyte response in peptide self-assembly

Yu, S., & Webber, M. J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01860e · Cited by 14

Charge‐Reversal Polymer Nano‐modulators for Photodynamic Immunotherapy of Cancer

He, S., Li, J., Cheng, P., Zeng, Z., Zhang, C., Duan, H., & Pu, K. (2021) · Angewandte Chemie · doi:10.1002/ange.202106392 · Cited by 13

Multi-level arch characteristics and flow enhancement regulation of nano powders discharged from silo

Zhu, L., Lu, H., Guo, X., & Liu, H. (2022) · Chemical Engineering Science · doi:10.1016/j.ces.2022.117492 · Cited by 13

Tumor Antigen Loaded Nanovaccine Induced NIR‐Activated Inflammation for Enhanced Antigen Presentation During Immunotherapy of Tumors

Li, W., Fan, J., Zheng, D., & Zhang, X. (2022) · Small · doi:10.1002/smll.202205193 · Cited by 13

Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer

Nair, S. T., Kamalasanan, K., Sneha, S., Pavithran, K., & Harb, H. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03454 · Cited by 14

Neoantigen-driven personalized tumor therapy: An update from discovery to clinical application

Xie, N., Shen, G., Huang, C., & Zhu, H. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003708 · Cited by 13

Polyphenol‐Based Assembly Nanosystems as Multifunctional Biopharmaceutical Platform

Jiang, X. Y., Zhang, J., Lo, P. K., & Mao, Z. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200168 · Cited by 12

Quantitatively Lighting up the Spatial Organization of CD47/SIRPα Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy

Wei, Y., Zhao, M., He, T., Chen, N., Rao, L., Chen, L., Zhang, Y., Yang, Y., & Yuan, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06709 · Cited by 12

Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy

Sui, X., Jin, T., Liu, T., Wu, S., Wu, Y., Tang, Z., Ren, Y., Ni, D., Yao, Z., & Zhang, H. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00804 · Cited by 12

Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer

Haegebaert, R., Kempers, M., Ceelen, W. P., Lentacker, I., & Remaut, K. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.01.002 · Cited by 12

Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy

Zhu, Z., Li, S., Yin, X., Sun, K., Song, J., Ren, W., Gao, L., & Zhi, K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130351 · Cited by 13

Nanotechnology synergized immunoengineering for cancer

Chauhan, D. S., Dhasmana, A., Laskar, P., Prasad, R., Jain, N. K., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.010 · Cited by 27

Challenges and opportunities of nanotechnology in cancer immunotherapy

Lee, D., Huntoon, K. M., Jiang, W., & Kim, B. Y. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00024-3 · Cited by 8

The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective

Li, Y., Ayala‐Orozco, C., Rauta, P. R., & Krishnan, S. (2019) · Nanoscale · doi:10.1039/c9nr05371a · Cited by 84

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics

Zhou, L., Zou, M., Xu, Y., Lin, P., Lei, C., & Xia, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.864301 · Cited by 78

Nanoparticle‐Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions

Liu, J., Zhang, R., & Xu, Z. P. (2019) · Small · doi:10.1002/smll.201900262 · Cited by 161